Dr. John H. Fullerton Meets With Avanir Pharmaceuticals Scientists In Los Angeles
Dr. John H. Fullerton, leader of the Clinical Research Division of Hampton Health, Ltd. in San Francisco, CA met with Avanir Pharmaceuticals scientists at the Annual American Association for Geriatric Psychiatry (AAGP) in May 2013. Dr. Fullerton is engaged as a Principal Investigator for Avanir in the Prism II Trials for the study of Pseudobulbar affect (PBA) disorder.
- San Francisco, CA (1888PressRelease) June 05, 2013 - Dr. John H. Fullerton of Hampton Health, Ltd. in San Francisco, CA met with Avanir Pharmaceuticals scientists at the AAGP (American Association for Geriatric Psychiatry) Annual Conference in Los Angeles earlier this month.
Dr. Fullerton, leader of the Clinical Research Division of Hampton Health, Ltd. is a Principal Investigator for the Avanir Pharmaceuticals Prism II Clinical Trails in the study of Pseudobulbar affect (PBA), a disorder of 'disinhibition' of emotional expression characterized by uncontrollable episodes of crying or laughing, without an apparent stimulus to trigger the response.
The Hampton Health, Ltd. Clinical Research Division has proven to be one of the top sites for the study, with Dr. Fullerton providing input and "clarity" for the study proceedings directly with Avanir scientists as well as the American Psychiatric Association.
As Vice President and Co-Chair of the Policy Committee of the CA Chapter of AMDA (American Medical Directors Association), Dr. Fullerton has been actively seeking non-psychoactive "solutions" to behavioral manifestations of dementia, CVA (Stroke) and TBI (Traumatic Brain Injury) and to cut down on the use of controversial psychoactive agents to manage behavior in patients with dementia. "This novel approach to PBA management [through the PRISM II Trial] has the potential to seriously reduce the psychotropic drug usage in one-third of dementia patients with projected PBA behavioral manifestations in our SNF's (Skilled Nursing Facilities) and our dementia units within assisted living facilities across the state and the US".
Dr. John H. Fullerton is Board Certified in Internal Medicine, Geriatric Medicine, Addiction Medicine, Toxicology and Hospice & LTC Medical Direction with active licenses in both California and Florida. His practice Hampton Health, Ltd. is located in San Francisco and Marin County.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam